This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

6 Strong Buys Breaking Near 52-Week Highs

JNJ Chart JNJ data by YCharts

Johnson & Johnson (JNJ - Get Report)

Background: Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. Founded in 1886, it is based in New Brunswick, N.J. Johnson & Johnson trades an average of 10 million shares per day with a market cap of $191 billion.

52-Week High: $69.75 TheStreet'sJim Cramer writes about Johnson & Johnson in The Market's Unheeded Flashing Signals

More than half the analysts covering Johnson & Johnson rate it as a buy or strong buy. Fifteen of the 26 analysts covering the company give a buy recommendation. Eleven analysts rate it a hold, and none of the analysts recommend selling.

The stock increased in value 11% during the last year, and the average analyst target price for Johnson & Johnson is $73.80.

This stock currently has an annualized dividend of $2.44, yielding 3.5%. The yield alone almost justifies an allocation of some capital. Not everyone is convinced buying is the correct choice, though. Along with the 11 analysts with hold ratings, short-sellers are taking an interest.

With short interest above 5%, investors will want to monitor changes to know whether short-sellers turn up the warning signals. Otherwise, the current 6% of the float short is relatively small and not a major concern.

From a technical perspective, the chart on Johnson & Johnson looks interesting. The widely followed moving averages and price action are strongly bullish. Johnson & Johnson shareholders have to be pleased right now. Don't be surprised to see Johnson & Johnson over $70 a share, and within 10 to 15 days.
6 of 7

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
HOV $1.57 0.00%
JNJ $112.88 0.00%
NWL $46.91 0.00%
RF $9.04 0.00%
SNV $29.78 0.00%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs